ADHD services for adults
Awareness of ADHD is rising, and demand for diagnosis and support services continues to grow. To meet this demand, it's essential that local services adapt to ensure they are accessible and meet the needs of the community.
Current challenges
The current service model is diagnosis rather than needs-led. This means people who may be struggling are not getting the early support they need.
The focus on diagnosis is also driving significant growth in demand for ADHD assessments. Not all people referred to assessment services need a formal diagnosis. If this is not addressed, the demand for diagnosis will keep growing. As the number of people now being referred for an assessment is far more than the services were originally designed to cope with, waiting times are growing
The increasing costs of this rising demand are not affordable and are putting a huge strain on NHS budgets.
There are many NHS and Independent Sector organisations providing ADHD assessments for our local population, which is leading to inconsistencies in the way care is accessed and provided.
For these reasons, the way we deliver our Adult ADHD services in Cheshire and Merseyside has to urgently change so they can better understand and meet people’s needs.
Our vision
Our vision for transformed Adult ADHD services in Cheshire and Merseyside is one that seeks to:
- consistently understand need
- increase the ability for more people to access support to meet their needs without a requirement for a formal diagnosis
- increase diagnostic capacity through a new primary care service and
- ensure sufficient secondary care provision for those with the most complex needs.
New model
A new care model is currently being rolled out across Cheshire and Merseyside. It seeks to ensure everyone who needs help with suspected ADHD symptoms is supported, rather than just those people who are diagnosed with ADHD.
It does this by being needs-led, not diagnosis-led, focusing on helping people access early support to manage their symptoms. Referrals to diagnostic assessment services remain available for those with symptoms that meet specific clinical criteria.
New primary care services are at the heart of this model, working with people to better understand their needs and to help them to access relevant information, education and support. GPs with additional ADHD training will also have the ability to undertake assessments for those who need it.
More information will be provided as this new innovative approach is rolled out, commencing in Cheshire West, Liverpool and Wirral.
Commissioning policy
NHS Cheshire and Merseyside has introduced a commissioning policy from 23 December 2025 to ensure that, for new patients referred from this date, there is provision of a consistent level of service for adult patients with suspected ADHD, as well as ensuring delivery of a more integrated referral assessment, diagnosis and treatment pathway, thereby preventing patients from experiencing a differential level of care/pathway depending on which provider they are referred to for support.
The commissioning policy follows a robust evidence base, in line with NICE guidance and the Royal College of Psychiatrists recommendations.
NHS Cheshire and Merseyside is implementing a clear referral threshold, whereby a diagnostic assessment is only offered if an adult’s (18 years and above) ADHD symptoms continue to cause significant functional impairment in at least two life domains and environmental modifications have been implemented and reviewed.
Domains refer to key areas of daily functioning that are commonly affected by ADHD, including interpersonal relationships, educational progress and learning, occupational performance and employment, risk awareness and safety (e.g. driving, financial management), and self-care.
In addition, the initial diagnostic appointment in the ADHD assessment pathway should be conducted face-to-face, and a mandatory face-to-face appointment for a physical health review is required before initiating pharmacological treatment. This allows for a comprehensive assessment and baseline physical investigations, which will inform the safety and appropriateness of initiating pharmacological treatment for ADHD. Clinical decisions must be based on reliable observations, and a recent prevention of future deaths report supports this approach.
The full policy can be accessed here.